Results 161 to 170 of about 2,501,794 (292)

How to invent a new business model based on crowdsourcing: the Crowdspirit ® case [PDF]

Chesbrough's work on open innovation provides a theoretical framework to understand how firms can access external knowledge in order to support their R&D processes.
Marie-Laurence Caron-Fasan, Valérie Chanal   +1 more
core  

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

Quantitative proteomic analysis reveals different characteristics of bladder cancer cells after exposure to bisphenol A

FEBS Open Bio, EarlyView.
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu, Lanlan Li, Wenjuan Jia, Hanzhong Feng, Xiaoquan Yu, Youli Zhao, Fengzhi Yuan, Hui Ding, Junqiang Tian, Yong‐Xing He, Zhiping Wang   +10 more
wiley   +1 more source

The role of open innovation, hotel service quality and marketing strategy in hotel business performance. [PDF]

Heliyon, 2022
Azhar Mohd Harif MA, Nawaz M, Hameed WU.
europepmc   +1 more source

Proteasomal degradation of intracellularly expressed Amblyomin‐X limits suicide gene therapy potential in melanoma cells

FEBS Open Bio, EarlyView.
This study explores the feasibility of expressing the antitumoral protein Amblyomin‐X through a suicide gene therapy approach and investigates its intracellular fate after gene delivery. Although the gene is efficiently expressed, melanoma cells rapidly degrade the Amblyomin‐X protein via proteasome activity.
Victor Dal Posolo Cinel, Carlos DeOcesano Pereira, Aline Ramos Maia Lobba, Melissa Regina Fessel, Ana Marisa Chudzinski‐Tavassi   +4 more
wiley   +1 more source

Mapping the conceptual structure of research on open innovation in university-industry collaborations: a bibliometric analysis. [PDF]

Front Res Metr Anal
Ballesteros-Ballesteros VA, Zárate-Torres RA.   +1 more
europepmc   +1 more source

The Notion of Coopetition-Based Open-Innovation in Business Practices: A Model to Accelerate Firm Performance. [PDF]

Front Psychol, 2022
Avotra AARN, Chengang Y, Said KSM, Chu C, Xiang L.   +4 more
europepmc   +1 more source

Six Challenges in Platform Licensing and Open Innovation [PDF]

This article describes six common challenges of design, incentives, and governance that arise in establishing platform businesses. It also proposes solutions.
Geoffrey PARKER, Marshall VAN ALSTYNE
core  

Digital twins to accelerate target identification and drug development for immune‐mediated disorders

FEBS Open Bio, EarlyView.
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley   +1 more source

Retraction: The construction of ecosystem and collaboration platform for enterprise open innovation. [PDF]

Front Psychol
Frontiers Editorial Office.
europepmc   +1 more source